Item 5.07 Submission of Matters to a Vote of Security Holders.
The 2022 Annual Meeting of Stockholders (the “Annual Meeting”) of Cassava Sciences, Inc. (the “Company”) was held at approximately 10 a.m. Central Time on May 5, 2022, pursuant to the Notice of Annual Meeting of Stockholders dated March 24, 2022 and duly delivered to all Company stockholders of record as of March 15, 2022. Of the 40,022,394 shares of the Company’s common stock entitled to vote at the Annual Meeting, 24,301,757 shares, or approximately 61%, were represented at the Annual Meeting virtually or by proxy, constituting a quorum. At the Annual Meeting, the Company’s stockholders voted on four proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on March 24, 2022. The following is a brief description of each matter voted on and the certified results, including the number of votes cast for and against each matter, and if applicable, the number of abstentions and broker non-votes with respect to each matter.
Proposal One – Two (2) nominees for election to the Board of Directors were elected to serve for a three-year term, and until their successors are duly elected and qualified, based upon the following votes:
| | | | | | | |
Director | | For | | Withheld | | Broker Non-Vote | |
Nadav Friedmann, Ph.D., M.D. | | 7,809,513 | | 2,839,913 | | 13,652,331 | |
Michael J. O’Donnell | | 7,229,346 | | 3,420,080 | | 13,652,331 | |
Proposal Two – Amendment No. 1 to the Cassava Sciences, Inc. 2018 Omnibus Incentive Plan, which increases the authorized number of shares by 4,000,000, so that a total of 5,000,000 shares are authorized to be granted under the Cassava Sciences, Inc. 2018 Omnibus Incentive Plan, as amended, was approved based upon the following votes:
| | | | | | | |
| For | | Against | | Abstain | | Broker Non -Vote |
| 6,393,029 | | 4,108,794 | | 147,603 | | 13,652,331 |
Proposal Three – The appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2022, was ratified based upon the following votes:
| | | | | | |
| For | | Against | | Abstain | |
| 23,586,882 | | 417,660 | | 297,215 | |
Proposal Four – The 2021 executive compensation for the Company’s named executive officers was approved, on a non-binding advisory vote, based upon the following votes:
| | | | | | | |
| For | | Against | | Abstain | | Broker Non -Vote |
| 5,993,989 | | 4,299,563 | | 355,874 | | 13,652,331 |